The global Cardiovascular and Cerebrovascular API market was valued at US$ 3072.7 million in 2023 and is anticipated to reach US$ 3710.9 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.

Cardiovascular and Cerebrovascular API Market

Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.

China is the main production area of cardiovascular and cerebrovascular raw materials, with a market share of more than 65%, followed by India and Europe.

The key manufacturers are Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Lepu Pharmaceutical, Zhejiang Jiangbei Pharmaceutical, DR.Reddy, Glenmerk, Cipla, MSN Life Sciences etc. Zhejiang Huahai Pharmaceutical Co., Ltd. is the largest producer of cardiovascular and cerebrovascular raw materials in China region market and global market, accounting for more than 10%.

This report aims to provide a comprehensive presentation of the global market for Cardiovascular and Cerebrovascular API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular and Cerebrovascular API.

Report Scope

The Cardiovascular and Cerebrovascular API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiovascular and Cerebrovascular API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cardiovascular and Cerebrovascular API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cardiovascular and Cerebrovascular API Market Report

Report Metric	Details
Report Name	Cardiovascular and Cerebrovascular API Market
Accounted market size in 2023	US$ 3072.7 million
Forecasted market size in 2030	US$ 3710.9 million
CAGR	2.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Sartans Cardiovascular and Cerebrovascular API Statins Cardiovascular and Cerebrovascular API Puri Cardiovascular and Cerebrovascular API
Segment by Application	Oral Drugs Injection Drugs
Production by Region	North America Europe China India
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Lepu Pharmaceutical, Zhejiang Jiangbei Pharmaceutical, DR.Reddy, Glenmerk, Cipla, MSN Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiovascular and Cerebrovascular API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Cardiovascular and Cerebrovascular API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Cardiovascular and Cerebrovascular API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Cardiovascular and Cerebrovascular API Market growing?

Ans: The Cardiovascular and Cerebrovascular API Market witnessing a CAGR of 2.7% during the forecast period 2024-2030.

What is the Cardiovascular and Cerebrovascular API Market size in 2030?

Ans: The Cardiovascular and Cerebrovascular API Market size in 2030 will be US$ 3710.9 million.

What is the Cardiovascular and Cerebrovascular API Market production share by region?

Ans: China is the main production area of cardiovascular and cerebrovascular raw materials, with a market share of more than 65%, followed by India and Europe.

Who are the main players in the Cardiovascular and Cerebrovascular API Market report?

Ans: The main players in the Cardiovascular and Cerebrovascular API Market are Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Lepu Pharmaceutical, Zhejiang Jiangbei Pharmaceutical, DR.Reddy, Glenmerk, Cipla, MSN Life Sciences

What are the Application segmentation covered in the Cardiovascular and Cerebrovascular API Market report?

Ans: The Applications covered in the Cardiovascular and Cerebrovascular API Market report are Oral Drugs, Injection Drugs

What are the Type segmentation covered in the Cardiovascular and Cerebrovascular API Market report?

Ans: The Types covered in the Cardiovascular and Cerebrovascular API Market report are Sartans Cardiovascular and Cerebrovascular API, Statins Cardiovascular and Cerebrovascular API, Puri Cardiovascular and Cerebrovascular API

1 Cardiovascular and Cerebrovascular API Market Overview

1.1 Product Definition

1.2 Cardiovascular and Cerebrovascular API Segment by Type

1.2.1 Global Cardiovascular and Cerebrovascular API Market Value Growth Rate Analysis by Type 2023 VS 2030

1.2.2 Sartans Cardiovascular and Cerebrovascular API

1.2.3 Statins Cardiovascular and Cerebrovascular API

1.2.4 Puri Cardiovascular and Cerebrovascular API

1.3 Cardiovascular and Cerebrovascular API Segment by Application

1.3.1 Global Cardiovascular and Cerebrovascular API Market Value Growth Rate Analysis by Application: 2023 VS 2030

1.3.2 Oral Drugs

1.3.3 Injection Drugs

1.4 Global Market Growth Prospects

1.4.1 Global Cardiovascular and Cerebrovascular API Production Value Estimates and Forecasts (2019-2030)

1.4.2 Global Cardiovascular and Cerebrovascular API Production Capacity Estimates and Forecasts (2019-2030)

1.4.3 Global Cardiovascular and Cerebrovascular API Production Estimates and Forecasts (2019-2030)

1.4.4 Global Cardiovascular and Cerebrovascular API Market Average Price Estimates and Forecasts (2019-2030)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Cardiovascular and Cerebrovascular API Production Market Share by Manufacturers (2019-2024)

2.2 Global Cardiovascular and Cerebrovascular API Production Value Market Share by Manufacturers (2019-2024)

2.3 Global Key Players of Cardiovascular and Cerebrovascular API, Industry Ranking, 2022 VS 2023 VS 2024

2.4 Global Cardiovascular and Cerebrovascular API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.5 Global Cardiovascular and Cerebrovascular API Average Price by Manufacturers (2019-2024)

2.6 Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Product Offered and Application

2.8 Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Date of Enter into This Industry

2.9 Cardiovascular and Cerebrovascular API Market Competitive Situation and Trends

2.9.1 Cardiovascular and Cerebrovascular API Market Concentration Rate

2.9.2 Global 5 and 10 Largest Cardiovascular and Cerebrovascular API Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Cardiovascular and Cerebrovascular API Production by Region

3.1 Global Cardiovascular and Cerebrovascular API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

3.2 Global Cardiovascular and Cerebrovascular API Production Value by Region (2019-2030)

3.2.1 Global Cardiovascular and Cerebrovascular API Production Value Market Share by Region (2019-2024)

3.2.2 Global Forecasted Production Value of Cardiovascular and Cerebrovascular API by Region (2025-2030)

3.3 Global Cardiovascular and Cerebrovascular API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

3.4 Global Cardiovascular and Cerebrovascular API Production by Region (2019-2030)

3.4.1 Global Cardiovascular and Cerebrovascular API Production Market Share by Region (2019-2024)

3.4.2 Global Forecasted Production of Cardiovascular and Cerebrovascular API by Region (2025-2030)

3.5 Global Cardiovascular and Cerebrovascular API Market Price Analysis by Region (2019-2024)

3.6 Global Cardiovascular and Cerebrovascular API Production and Value, Year-over-Year Growth

3.6.1 North America Cardiovascular and Cerebrovascular API Production Value Estimates and Forecasts (2019-2030)

3.6.2 Europe Cardiovascular and Cerebrovascular API Production Value Estimates and Forecasts (2019-2030)

3.6.3 China Cardiovascular and Cerebrovascular API Production Value Estimates and Forecasts (2019-2030)

3.6.4 India Cardiovascular and Cerebrovascular API Production Value Estimates and Forecasts (2019-2030)

4 Cardiovascular and Cerebrovascular API Consumption by Region

4.1 Global Cardiovascular and Cerebrovascular API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

4.2 Global Cardiovascular and Cerebrovascular API Consumption by Region (2019-2030)

4.2.1 Global Cardiovascular and Cerebrovascular API Consumption by Region (2019-2024)

4.2.2 Global Cardiovascular and Cerebrovascular API Forecasted Consumption by Region (2025-2030)

4.3 North America

4.3.1 North America Cardiovascular and Cerebrovascular API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.3.2 North America Cardiovascular and Cerebrovascular API Consumption by Country (2019-2030)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Cardiovascular and Cerebrovascular API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.4.2 Europe Cardiovascular and Cerebrovascular API Consumption by Country (2019-2030)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Cardiovascular and Cerebrovascular API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030

4.5.2 Asia Pacific Cardiovascular and Cerebrovascular API Consumption by Region (2019-2030)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Cardiovascular and Cerebrovascular API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.6.2 Latin America, Middle East & Africa Cardiovascular and Cerebrovascular API Consumption by Country (2019-2030)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

5 Segment by Type

5.1 Global Cardiovascular and Cerebrovascular API Production by Type (2019-2030)

5.1.1 Global Cardiovascular and Cerebrovascular API Production by Type (2019-2024)

5.1.2 Global Cardiovascular and Cerebrovascular API Production by Type (2025-2030)

5.1.3 Global Cardiovascular and Cerebrovascular API Production Market Share by Type (2019-2030)

5.2 Global Cardiovascular and Cerebrovascular API Production Value by Type (2019-2030)

5.2.1 Global Cardiovascular and Cerebrovascular API Production Value by Type (2019-2024)

5.2.2 Global Cardiovascular and Cerebrovascular API Production Value by Type (2025-2030)

5.2.3 Global Cardiovascular and Cerebrovascular API Production Value Market Share by Type (2019-2030)

5.3 Global Cardiovascular and Cerebrovascular API Price by Type (2019-2030)

6 Segment by Application

6.1 Global Cardiovascular and Cerebrovascular API Production by Application (2019-2030)

6.1.1 Global Cardiovascular and Cerebrovascular API Production by Application (2019-2024)

6.1.2 Global Cardiovascular and Cerebrovascular API Production by Application (2025-2030)

6.1.3 Global Cardiovascular and Cerebrovascular API Production Market Share by Application (2019-2030)

6.2 Global Cardiovascular and Cerebrovascular API Production Value by Application (2019-2030)

6.2.1 Global Cardiovascular and Cerebrovascular API Production Value by Application (2019-2024)

6.2.2 Global Cardiovascular and Cerebrovascular API Production Value by Application (2025-2030)

6.2.3 Global Cardiovascular and Cerebrovascular API Production Value Market Share by Application (2019-2030)

6.3 Global Cardiovascular and Cerebrovascular API Price by Application (2019-2030)

7 Key Companies Profiled

7.1 Zhuhai Rundu Pharmaceutical

7.1.1 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

7.1.2 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Product Portfolio

7.1.3 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Production, Value, Price and Gross Margin (2019-2024)

7.1.4 Zhuhai Rundu Pharmaceutical Main Business and Markets Served

7.1.5 Zhuhai Rundu Pharmaceutical Recent Developments/Updates

7.2 Ningbo Menovo Pharmaceutical

7.2.1 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

7.2.2 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Product Portfolio

7.2.3 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Production, Value, Price and Gross Margin (2019-2024)

7.2.4 Ningbo Menovo Pharmaceutical Main Business and Markets Served

7.2.5 Ningbo Menovo Pharmaceutical Recent Developments/Updates

7.3 Zhejiang Huahai Pharmaceutical

7.3.1 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

7.3.2 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Product Portfolio

7.3.3 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Production, Value, Price and Gross Margin (2019-2024)

7.3.4 Zhejiang Huahai Pharmaceutical Main Business and Markets Served

7.3.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates

7.4 Zhejiang Tianyu Pharmaceutical

7.4.1 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

7.4.2 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Product Portfolio

7.4.3 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Production, Value, Price and Gross Margin (2019-2024)

7.4.4 Zhejiang Tianyu Pharmaceutical Main Business and Markets Served

7.4.5 Zhejiang Tianyu Pharmaceutical Recent Developments/Updates

7.5 Zhejiang Hisun Pharmaceutical

7.5.1 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

7.5.2 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Product Portfolio

7.5.3 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Production, Value, Price and Gross Margin (2019-2024)

7.5.4 Zhejiang Hisun Pharmaceutical Main Business and Markets Served

7.5.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates

7.6 Zhejiang Lepu Pharmaceutical

7.6.1 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

7.6.2 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Product Portfolio

7.6.3 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Production, Value, Price and Gross Margin (2019-2024)

7.6.4 Zhejiang Lepu Pharmaceutical Main Business and Markets Served

7.6.5 Zhejiang Lepu Pharmaceutical Recent Developments/Updates

7.7 Zhejiang Jiangbei Pharmaceutical

7.7.1 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

7.7.2 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Product Portfolio

7.7.3 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Production, Value, Price and Gross Margin (2019-2024)

7.7.4 Zhejiang Jiangbei Pharmaceutical Main Business and Markets Served

7.7.5 Zhejiang Jiangbei Pharmaceutical Recent Developments/Updates

7.8 DR.Reddy

7.8.1 DR.Reddy Cardiovascular and Cerebrovascular API Corporation Information

7.8.2 DR.Reddy Cardiovascular and Cerebrovascular API Product Portfolio

7.8.3 DR.Reddy Cardiovascular and Cerebrovascular API Production, Value, Price and Gross Margin (2019-2024)

7.8.4 DR.Reddy Main Business and Markets Served

7.7.5 DR.Reddy Recent Developments/Updates

7.9 Glenmerk

7.9.1 Glenmerk Cardiovascular and Cerebrovascular API Corporation Information

7.9.2 Glenmerk Cardiovascular and Cerebrovascular API Product Portfolio

7.9.3 Glenmerk Cardiovascular and Cerebrovascular API Production, Value, Price and Gross Margin (2019-2024)

7.9.4 Glenmerk Main Business and Markets Served

7.9.5 Glenmerk Recent Developments/Updates

7.10 Cipla

7.10.1 Cipla Cardiovascular and Cerebrovascular API Corporation Information

7.10.2 Cipla Cardiovascular and Cerebrovascular API Product Portfolio

7.10.3 Cipla Cardiovascular and Cerebrovascular API Production, Value, Price and Gross Margin (2019-2024)

7.10.4 Cipla Main Business and Markets Served

7.10.5 Cipla Recent Developments/Updates

7.11 MSN Life Sciences

7.11.1 MSN Life Sciences Cardiovascular and Cerebrovascular API Corporation Information

7.11.2 MSN Life Sciences Cardiovascular and Cerebrovascular API Product Portfolio

7.11.3 MSN Life Sciences Cardiovascular and Cerebrovascular API Production, Value, Price and Gross Margin (2019-2024)

7.11.4 MSN Life Sciences Main Business and Markets Served

7.11.5 MSN Life Sciences Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Cardiovascular and Cerebrovascular API Industry Chain Analysis

8.2 Cardiovascular and Cerebrovascular API Key Raw Materials

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Cardiovascular and Cerebrovascular API Production Mode & Process

8.4 Cardiovascular and Cerebrovascular API Sales and Marketing

8.4.1 Cardiovascular and Cerebrovascular API Sales Channels

8.4.2 Cardiovascular and Cerebrovascular API Distributors

8.5 Cardiovascular and Cerebrovascular API Customers

9 Cardiovascular and Cerebrovascular API Market Dynamics

9.1 Cardiovascular and Cerebrovascular API Industry Trends

9.2 Cardiovascular and Cerebrovascular API Market Drivers

9.3 Cardiovascular and Cerebrovascular API Market Challenges

9.4 Cardiovascular and Cerebrovascular API Market Restraints

10 Research Finding and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Zhuhai Rundu Pharmaceutical

Ningbo Menovo Pharmaceutical

Zhejiang Huahai Pharmaceutical

Zhejiang Tianyu Pharmaceutical

Zhejiang Hisun Pharmaceutical

Zhejiang LEPU Pharmaceutical

Zhejiang Jiangbei Pharmaceutical

List of Tables

Table 1. Global Cardiovascular and Cerebrovascular API Market Value by Type, (US$ Million) & (2023 VS 2030)

Table 2. Global Cardiovascular and Cerebrovascular API Market Value by Application, (US$ Million) & (2023 VS 2030)

Table 3. Global Cardiovascular and Cerebrovascular API Production Capacity (MT) by Manufacturers in 2023

Table 4. Global Cardiovascular and Cerebrovascular API Production by Manufacturers (2019-2024) & (MT)

Table 5. Global Cardiovascular and Cerebrovascular API Production Market Share by Manufacturers (2019-2024)

Table 6. Global Cardiovascular and Cerebrovascular API Production Value by Manufacturers (2019-2024) & (US$ Million)

Table 7. Global Cardiovascular and Cerebrovascular API Production Value Share by Manufacturers (2019-2024)

Table 8. Global Cardiovascular and Cerebrovascular API Industry Ranking 2022 VS 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cardiovascular and Cerebrovascular API as of 2023)

Table 10. Global Market Cardiovascular and Cerebrovascular API Average Price by Manufacturers (USD/Kg) & (2019-2024)

Table 11. Manufacturers Cardiovascular and Cerebrovascular API Production Sites and Area Served

Table 12. Manufacturers Cardiovascular and Cerebrovascular API Product Types

Table 13. Global Cardiovascular and Cerebrovascular API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion

Table 15. Global Cardiovascular and Cerebrovascular API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 16. Global Cardiovascular and Cerebrovascular API Production Value (US$ Million) by Region (2019-2024)

Table 17. Global Cardiovascular and Cerebrovascular API Production Value Market Share by Region (2019-2024)

Table 18. Global Cardiovascular and Cerebrovascular API Production Value (US$ Million) Forecast by Region (2025-2030)

Table 19. Global Cardiovascular and Cerebrovascular API Production Value Market Share Forecast by Region (2025-2030)

Table 20. Global Cardiovascular and Cerebrovascular API Production Comparison by Region: 2019 VS 2023 VS 2030 (MT)

Table 21. Global Cardiovascular and Cerebrovascular API Production (MT) by Region (2019-2024)

Table 22. Global Cardiovascular and Cerebrovascular API Production Market Share by Region (2019-2024)

Table 23. Global Cardiovascular and Cerebrovascular API Production (MT) Forecast by Region (2025-2030)

Table 24. Global Cardiovascular and Cerebrovascular API Production Market Share Forecast by Region (2025-2030)

Table 25. Global Cardiovascular and Cerebrovascular API Market Average Price (USD/Kg) by Region (2019-2024)

Table 26. Global Cardiovascular and Cerebrovascular API Market Average Price (USD/Kg) by Region (2025-2030)

Table 27. Global Cardiovascular and Cerebrovascular API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (MT)

Table 28. Global Cardiovascular and Cerebrovascular API Consumption by Region (2019-2024) & (MT)

Table 29. Global Cardiovascular and Cerebrovascular API Consumption Market Share by Region (2019-2024)

Table 30. Global Cardiovascular and Cerebrovascular API Forecasted Consumption by Region (2025-2030) & (MT)

Table 31. Global Cardiovascular and Cerebrovascular API Forecasted Consumption Market Share by Region (2019-2024)

Table 32. North America Cardiovascular and Cerebrovascular API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)

Table 33. North America Cardiovascular and Cerebrovascular API Consumption by Country (2019-2024) & (MT)

Table 34. North America Cardiovascular and Cerebrovascular API Consumption by Country (2025-2030) & (MT)

Table 35. Europe Cardiovascular and Cerebrovascular API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)

Table 36. Europe Cardiovascular and Cerebrovascular API Consumption by Country (2019-2024) & (MT)

Table 37. Europe Cardiovascular and Cerebrovascular API Consumption by Country (2025-2030) & (MT)

Table 38. Asia Pacific Cardiovascular and Cerebrovascular API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (MT)

Table 39. Asia Pacific Cardiovascular and Cerebrovascular API Consumption by Region (2019-2024) & (MT)

Table 40. Asia Pacific Cardiovascular and Cerebrovascular API Consumption by Region (2025-2030) & (MT)

Table 41. Latin America, Middle East & Africa Cardiovascular and Cerebrovascular API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)

Table 42. Latin America, Middle East & Africa Cardiovascular and Cerebrovascular API Consumption by Country (2019-2024) & (MT)

Table 43. Latin America, Middle East & Africa Cardiovascular and Cerebrovascular API Consumption by Country (2025-2030) & (MT)

Table 44. Global Cardiovascular and Cerebrovascular API Production (MT) by Type (2019-2024)

Table 45. Global Cardiovascular and Cerebrovascular API Production (MT) by Type (2025-2030)

Table 46. Global Cardiovascular and Cerebrovascular API Production Market Share by Type (2019-2024)

Table 47. Global Cardiovascular and Cerebrovascular API Production Market Share by Type (2025-2030)

Table 48. Global Cardiovascular and Cerebrovascular API Production Value (US$ Million) by Type (2019-2024)

Table 49. Global Cardiovascular and Cerebrovascular API Production Value (US$ Million) by Type (2025-2030)

Table 50. Global Cardiovascular and Cerebrovascular API Production Value Share by Type (2019-2024)

Table 51. Global Cardiovascular and Cerebrovascular API Production Value Share by Type (2025-2030)

Table 52. Global Cardiovascular and Cerebrovascular API Price (USD/Kg) by Type (2019-2024)

Table 53. Global Cardiovascular and Cerebrovascular API Price (USD/Kg) by Type (2025-2030)

Table 54. Global Cardiovascular and Cerebrovascular API Production (MT) by Application (2019-2024)

Table 55. Global Cardiovascular and Cerebrovascular API Production (MT) by Application (2025-2030)

Table 56. Global Cardiovascular and Cerebrovascular API Production Market Share by Application (2019-2024)

Table 57. Global Cardiovascular and Cerebrovascular API Production Market Share by Application (2025-2030)

Table 58. Global Cardiovascular and Cerebrovascular API Production Value (US$ Million) by Application (2019-2024)

Table 59. Global Cardiovascular and Cerebrovascular API Production Value (US$ Million) by Application (2025-2030)

Table 60. Global Cardiovascular and Cerebrovascular API Production Value Share by Application (2019-2024)

Table 61. Global Cardiovascular and Cerebrovascular API Production Value Share by Application (2025-2030)

Table 62. Global Cardiovascular and Cerebrovascular API Price (USD/Kg) by Application (2019-2024)

Table 63. Global Cardiovascular and Cerebrovascular API Price (USD/Kg) by Application (2025-2030)

Table 64. Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

Table 65. Zhuhai Rundu Pharmaceutical Specification and Application

Table 66. Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 67. Zhuhai Rundu Pharmaceutical Main Business and Markets Served

Table 68. Zhuhai Rundu Pharmaceutical Recent Developments/Updates

Table 69. Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

Table 70. Ningbo Menovo Pharmaceutical Specification and Application

Table 71. Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 72. Ningbo Menovo Pharmaceutical Main Business and Markets Served

Table 73. Ningbo Menovo Pharmaceutical Recent Developments/Updates

Table 74. Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

Table 75. Zhejiang Huahai Pharmaceutical Specification and Application

Table 76. Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 77. Zhejiang Huahai Pharmaceutical Main Business and Markets Served

Table 78. Zhejiang Huahai Pharmaceutical Recent Developments/Updates

Table 79. Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

Table 80. Zhejiang Tianyu Pharmaceutical Specification and Application

Table 81. Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 82. Zhejiang Tianyu Pharmaceutical Main Business and Markets Served

Table 83. Zhejiang Tianyu Pharmaceutical Recent Developments/Updates

Table 84. Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

Table 85. Zhejiang Hisun Pharmaceutical Specification and Application

Table 86. Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 87. Zhejiang Hisun Pharmaceutical Main Business and Markets Served

Table 88. Zhejiang Hisun Pharmaceutical Recent Developments/Updates

Table 89. Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

Table 90. Zhejiang Lepu Pharmaceutical Specification and Application

Table 91. Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 92. Zhejiang Lepu Pharmaceutical Main Business and Markets Served

Table 93. Zhejiang Lepu Pharmaceutical Recent Developments/Updates

Table 94. Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Corporation Information

Table 95. Zhejiang Jiangbei Pharmaceutical Specification and Application

Table 96. Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 97. Zhejiang Jiangbei Pharmaceutical Main Business and Markets Served

Table 98. Zhejiang Jiangbei Pharmaceutical Recent Developments/Updates

Table 99. DR.Reddy Cardiovascular and Cerebrovascular API Corporation Information

Table 100. DR.Reddy Specification and Application

Table 101. DR.Reddy Cardiovascular and Cerebrovascular API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 102. DR.Reddy Main Business and Markets Served

Table 103. DR.Reddy Recent Developments/Updates

Table 104. Glenmerk Cardiovascular and Cerebrovascular API Corporation Information

Table 105. Glenmerk Specification and Application

Table 106. Glenmerk Cardiovascular and Cerebrovascular API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 107. Glenmerk Main Business and Markets Served

Table 108. Glenmerk Recent Developments/Updates

Table 109. Cipla Cardiovascular and Cerebrovascular API Corporation Information

Table 110. Cipla Specification and Application

Table 111. Cipla Cardiovascular and Cerebrovascular API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 112. Cipla Main Business and Markets Served

Table 113. Cipla Recent Developments/Updates

Table 114. MSN Life Sciences Cardiovascular and Cerebrovascular API Corporation Information

Table 115. MSN Life Sciences Specification and Application

Table 116. MSN Life Sciences Cardiovascular and Cerebrovascular API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 117. MSN Life Sciences Main Business and Markets Served

Table 118. MSN Life Sciences Recent Developments/Updates

Table 119. Key Raw Materials Lists

Table 120. Raw Materials Key Suppliers Lists

Table 121. Cardiovascular and Cerebrovascular API Distributors List

Table 122. Cardiovascular and Cerebrovascular API Customers List

Table 123. Cardiovascular and Cerebrovascular API Market Trends

Table 124. Cardiovascular and Cerebrovascular API Market Drivers

Table 125. Cardiovascular and Cerebrovascular API Market Challenges

Table 126. Cardiovascular and Cerebrovascular API Market Restraints

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Cardiovascular and Cerebrovascular API

Figure 2. Global Cardiovascular and Cerebrovascular API Market Value by Type, (US$ Million) & (2023 VS 2030)

Figure 3. Global Cardiovascular and Cerebrovascular API Market Share by Type: 2023 VS 2030

Figure 4. Sartans Cardiovascular and Cerebrovascular API Product Picture

Figure 5. Statins Cardiovascular and Cerebrovascular API Product Picture

Figure 6. Puri Cardiovascular and Cerebrovascular API Product Picture

Figure 7. Global Cardiovascular and Cerebrovascular API Market Value by Application, (US$ Million) & (2023 VS 2030)

Figure 8. Global Cardiovascular and Cerebrovascular API Market Share by Application: 2023 VS 2030

Figure 9. Oral Drugs

Figure 10. Injection Drugs

Figure 11. Global Cardiovascular and Cerebrovascular API Production Value (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Cardiovascular and Cerebrovascular API Production Value (US$ Million) & (2019-2030)

Figure 13. Global Cardiovascular and Cerebrovascular API Production Capacity (MT) & (2019-2030)

Figure 14. Global Cardiovascular and Cerebrovascular API Production (MT) & (2019-2030)

Figure 15. Global Cardiovascular and Cerebrovascular API Average Price (USD/Kg) & (2019-2030)

Figure 16. Cardiovascular and Cerebrovascular API Report Years Considered

Figure 17. Cardiovascular and Cerebrovascular API Production Share by Manufacturers in 2023

Figure 18. Cardiovascular and Cerebrovascular API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 19. The Global 5 and 10 Largest Players: Market Share by Cardiovascular and Cerebrovascular API Revenue in 2023

Figure 20. Global Cardiovascular and Cerebrovascular API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 21. Global Cardiovascular and Cerebrovascular API Production Value Market Share by Region: 2019 VS 2023 VS 2030

Figure 22. Global Cardiovascular and Cerebrovascular API Production Comparison by Region: 2019 VS 2023 VS 2030 (MT)

Figure 23. Global Cardiovascular and Cerebrovascular API Production Market Share by Region: 2019 VS 2023 VS 2030

Figure 24. North America Cardiovascular and Cerebrovascular API Production Value (US$ Million) Growth Rate (2019-2030)

Figure 25. Europe Cardiovascular and Cerebrovascular API Production Value (US$ Million) Growth Rate (2019-2030)

Figure 26. China Cardiovascular and Cerebrovascular API Production Value (US$ Million) Growth Rate (2019-2030)

Figure 27. India Cardiovascular and Cerebrovascular API Production Value (US$ Million) Growth Rate (2019-2030)

Figure 28. Global Cardiovascular and Cerebrovascular API Consumption by Region: 2019 VS 2023 VS 2030 (MT)

Figure 29. Global Cardiovascular and Cerebrovascular API Consumption Market Share by Region: 2019 VS 2023 VS 2030

Figure 30. North America Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 31. North America Cardiovascular and Cerebrovascular API Consumption Market Share by Country (2019-2030)

Figure 32. Canada Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 33. U.S. Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 34. Europe Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 35. Europe Cardiovascular and Cerebrovascular API Consumption Market Share by Country (2019-2030)

Figure 36. Germany Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 37. France Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 38. U.K. Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 39. Italy Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 40. Russia Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 41. Asia Pacific Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 42. Asia Pacific Cardiovascular and Cerebrovascular API Consumption Market Share by Regions (2019-2030)

Figure 43. China Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 44. Japan Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 45. South Korea Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 46. China Taiwan Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 47. Southeast Asia Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 48. India Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 49. Latin America, Middle East & Africa Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 50. Latin America, Middle East & Africa Cardiovascular and Cerebrovascular API Consumption Market Share by Country (2019-2030)

Figure 51. Mexico Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 52. Brazil Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 53. Turkey Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 54. GCC Countries Cardiovascular and Cerebrovascular API Consumption and Growth Rate (2019-2024) & (MT)

Figure 55. Global Production Market Share of Cardiovascular and Cerebrovascular API by Type (2019-2030)

Figure 56. Global Production Value Market Share of Cardiovascular and Cerebrovascular API by Type (2019-2030)

Figure 57. Global Cardiovascular and Cerebrovascular API Price (USD/Kg) by Type (2019-2030)

Figure 58. Global Production Market Share of Cardiovascular and Cerebrovascular API by Application (2019-2030)

Figure 59. Global Production Value Market Share of Cardiovascular and Cerebrovascular API by Application (2019-2030)

Figure 60. Global Cardiovascular and Cerebrovascular API Price (USD/Kg) by Application (2019-2030)

Figure 61. Cardiovascular and Cerebrovascular API Value Chain

Figure 62. Cardiovascular and Cerebrovascular API Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Artery Imaging Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-37R6046

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global ECG Devices Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-23S9116

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Decentralized & POC Coagulation Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7S6333

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Transcatheter Aortic Valve Implantation (TAVI) System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-37M13084

Sun Apr 07 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions